Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Joseph Tucker
Recent news which mentions Joseph Tucker
Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
November 18, 2024
Tickers
ENVB
NEWS
Tags
Joseph Tucker
ENVB
Psychedelics earnings
From
Benzinga
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
November 12, 2024
Tickers
ENVB
NEWS
Tags
ENVB
Market News
Cannabis
From
Benzinga
Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
October 15, 2024
Tickers
ENVB
NEWS
Tags
Non/Hallucinogenic Psychedelic Compound
Enveric Biosciences
Benzinga
From
Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
Tickers
ATAI
ENVB
NEWS
Tags
Non/Hallucinogenic Psychedelics
Dillan DiNardo
ENVB
From
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
Tickers
CCC
ENVB
NEWS
Tags
Health Care
News
Market News
From
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
July 25, 2024
Tickers
DMT
ENVB
NEWS
Tags
Psychedelics mental health
Psychedelics
Benzinga
From
Benzinga
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
July 11, 2024
Tickers
ENVB
Tags
Benzinga
Psychedelics
Dr/ Joseph Tucker
From
Benzinga
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
May 16, 2024
Tickers
ENVB
NEWS
Tags
Psychedelic Medication
psychedelics addiction
Joseph Tucker
From
Benzinga
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
May 14, 2024
Tickers
ENVB
NEWS
Tags
Joseph Tucker
Microdosing
Justin Hanka
From
Benzinga
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
May 08, 2024
Tickers
ENVB
NEWS
Tags
News
Psychedelics
cannabis cancer
From
Benzinga
Enveric Completes Manufacturing Of Its Psilocin Prodrug To Supply Drug Material For Completion Of Preclinical Program
August 21, 2023
Tickers
ENVB
Tags
News
Psychedelics
Benzinga
From
Benzinga
Enveric Unveils Positive Results From Preclinical Studies Supporting Metabolic Profile Of Its Psilocin Prodrug For Anxiety
July 24, 2023
Tickers
ENVB
Tags
Joseph Tucker
ENVB
Markets
From
Benzinga
Enveric Unveils Positive Results From Animal Studies Of Its Psilocin Prodrug For Anxiety
July 17, 2023
Tickers
ENVB
Tags
Cannabis
Market News
Markets
From
Benzinga
Psychedelics Company Takes 'A Key Step' With New Formulation Of Its Psilocin Prodrug For Anxiety
June 26, 2023
Tickers
ENVB
Tags
premium
Penny Stocks
Psychedelics
From
Benzinga
Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives
June 05, 2023
Tickers
ENVB
Tags
Benzinga
Penny Stocks
premium
From
Benzinga
Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs
May 24, 2023
Tickers
ENVB
Tags
Markets
Cannabis
Market News
From
Benzinga
Enveric Releases Paper Detailing The Development Of Novel Psilocin Prodrugs For The Treatment Of Mental Health Disorders
May 22, 2023
Tickers
ENVB
Tags
Penny Stocks
premium
News
From
Benzinga
Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin
May 18, 2023
Tickers
ENVB
Tags
Joseph Tucker
ENVB
Cannabis
From
Benzinga
Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share
May 15, 2023
Tickers
ENVB
Tags
Penny Stocks
Earnings
News
From
Benzinga
EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
April 14, 2023
Tickers
ENVB
PSYBF
TRYPF
Tags
Markets
Market News
KCSA
From
Benzinga
Enveric Biosciences Files Provisional Patent For CBD+Celecoxib Conjugate For Osteoarthritis
February 08, 2022
Tickers
CBD
ENVB
Tags
ENVB
Markets
Education
From
Benzinga
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
December 10, 2021
Tickers
ENVB
TGODF
TLRY
Tags
Markets
Sean Bovingdon
Cannabis
From
Benzinga
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
September 17, 2021
Tickers
ENVB
Tags
Penny Stocks
Benzinga
ENVB
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.